Diabetes drug market in transition

Published: 2011-11-21 06:57:00

Updated: 2011-11-21 06:57:00

Handok Pharmaceutical’s Amaryl kept its number 1 ranking in local diabetes drug market, but struggles this year against Merck’s Januvia (sitagliptin) which succeeded in overtaking the top position in October.

Januvia’s October sales recorded 5.7 billion won, exceeding Amaryl sales of 5.3 billi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK